Introduction

Skin biopsy is a screening procedure in which a designated portion of skin is removed from the individual. It is a diagnostic procedure intended to provide information regarding skin anomalies. Using a scalpel or other surgical instruments, the sample is carefully excised and may be placed in culture media for further analysis, such as detecting growth patterns. 

Clinical features of toxic epidermal necrolysis

Toxic epidermal necrolysis (TEN) is a fatal and concerning skin condition characterised by widespread cell death in the epidermal layer. This condition causes the outermost layer of skin to detach, leading to extensive skin loss, fluid loss, and necrosis. In turn, it can result in severe complications, including infection and damage to underlying organs. 

Diagnostic challenges in TEN

Diagnosing TEN can be particularly challenging due to its clinical similarity to Stevens-Johnson syndrome (SJS). Both conditions share overlapping features, such as blistering, mucosal involvement, and other common anomalies caused by other disorders. Additionally, TEN develops progressively, and its initial symptoms–fever, malaise, and skin tenderness–are often nonspecific, further complicating early recognition. The variability in lesion appearance adds to diagnostic uncertainty. This variability, combined with the gradual onset, can result in delayed or incorrect diagnosis, hindering timely intervention.

Pathophysiology of toxic epidermal necrolysis

TEN is a hypersensitive condition caused by an overactive immune system. It is primarily mediated by cytotoxic T cells, which mistakenly target and destroy keratocytes, the skin cells of the epidermal layers. This immune attack is amplified by the release of pro-inflammatory cytokines like TNF-ɑ, IL-1, and IL-6, leading to enhanced inflammation and swelling. 

Genetic factors also play a role in the pathogenesis of TEN, and when combined with environmental triggers, contribute to the complexity and severity of this life-threatening condition. 

Skin biopsy in toxic epidermal necrolysis

To accurately diagnose TEN and understand its underlying pathology, healthcare providers rely on diagnostics procedures, with skin biopsy being the most definitive and widely used method. Conducted by a dermatologist, a skin biopsy is essential for distinguishing TEN from other skin conditions with similar symptoms, such as SJS. 

A skin biopsy offers valuable information in the following ways: 

1. Severity Assessment: Skin biopsy findings can provide insights into the severity of epidermal involvement, which may correlate with prognosis and guide treatment decisions
2. Differentiation from SJS: Histopathological features may assist in differentiating TEN from SJS, where the extent of epidermal necrosis and inflammatory infiltrates may be less pronounced

Histological features of TEN in skin biopsy

Following skin biopsy and potential tissue culture, histopathological analysis is essential for confirming the diagnosis of TEN. This involves a detailed examination of the microscopic features of the affected skin to distinguish normal vs. pathological changes. The following key histopathological findings are commonly observed in TEN:

• Epidermal Necrosis: The hallmark feature of TEN is the widespread necrosis of the epidermis, which can be seen as full-thickness epidermal detachment
• Subepidermal Blistering: A clear separation between the epidermis and dermis is commonly observed, forming subepidermal blisters
• Keratinocyte Apoptosis: Apoptotic keratinocytes, characterised by shrunken nuclei, can be seen throughout the epidermis
• Inflammatory Infiltrates: The dermis may show a mixed inflammatory infiltrate, primarily composed of lymphocytes, macrophages, and neutrophils
• Interface Dermatitis: A distinctive feature of TEN is interface dermatitis, where inflammatory cells infiltrate the dermo-epidermal junction

Limitations of skin biopsy in TEN

While skin biopsy is a valuable diagnostic tool in assessing epidermal damage and supporting the diagnosis of TEN, it is not without limitations:

• Reduced sensitivity in early stages:
  Skin biopsy is most effective in identifying the advanced histopathological features of TEN, but pathological changes may be subtle in the early stages. This can lead to reduced diagnostic sensitivity
• Lack of specificity:
  TEN shares overlapping clinical and histological features with other dermatological conditions, particularly SJS. This non-specificity can result in diagnostic ambiguity, especially when biopsy findings are inconclusive or do not fully meet classic criteria

Clinical impact of skin biopsy in confirming TEN

Skin biopsy is a highly practised and clinically impactful diagnostic procedure for the confirmation of TEN as follows. Its role extends beyond diagnosis to directly influencing treatment decisions in the following key ways: 

1. Confirming Drug-Induced TEN: A biopsy can confirm the diagnosis and distinguish it from other conditions, aiding in treatment decisions and identifying the specific drug responsible
2. Guiding Therapy: Histological confirmation can support decisions regarding systemic therapies, including corticosteroids, immunosuppressive agents, and other targeted therapies

Alternatives and complementary diagnostic tools

While skin biopsy is considered the gold standard for diagnosing TEN, its limitations, particularly in early detection and specificity, have led to the development and exploration of alternative and complementary diagnostic methods. These include: 

1. Serological Markers
2. Genetic Testing: In cases with suspected drug-induced TEN, genetic testing for certain HLA alleles may provide additional insights into susceptibility

Conclusion

TEN is a severe and potentially fatal dermatological condition characterised by widespread epidermal necrosis–the sudden and irreversible death of skin cells. Accurate and timely diagnosis is critical for effective management, and skin biopsy plays a central role in confirming the condition, assessing its severity, and guiding treatment decisions. 

FAQs

What is a skin biopsy, and why is it important for diagnosing TEN?

A skin biopsy involves the removal of a small portion of skin for examination under a microscope. In the case of TEN, a skin biopsy is crucial for confirming the diagnosis, differentiating it from other conditions, and assessing the severity of epidermal involvement.

What are the common symptoms of TEN that lead to the need for a skin biopsy?

TEN typically presents with widespread skin detachment, blisters, and necrosis of the epidermis, often accompanied by fever, malaise, and mucosal involvement. These symptoms overlap with other conditions like SJS, making a skin biopsy essential for an accurate diagnosis.

What are the main histological features seen in a skin biopsy for TEN?

Histological features of TEN include full-thickness epidermal necrosis, subepidermal blistering, keratinocyte apoptosis, inflammatory infiltrates (mainly lymphocytes and macrophages), and interface dermatitis (inflammation at the dermo-epidermal junction).

What are the limitations of using a skin biopsy to diagnose TEN?

Skin biopsy has limitations such as lower sensitivity in the ly stages of TEN, difficulty in distinguishing TEN from other similar conditions, and its inability to provide a clear diagnosis in cases with overlapping symptoms. These limitations sometimes necessitate the use of complementary diagnostic tools like serological markers or genetic testing.